Sfoglia per Autore
The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer
2017 F. Wang, X. Yu, X. Shen, G. Zhu, Y. Huang, R. Liu, D. Viola, R. Elisei, E. Puxeddu, L. Fugazzola, C. Colombo, B. Jarzab, A. Czarniecka, A. Lam, C. Mian, F. Vianello, L. Yip, G. Riesco-Eizaguirre, P. Santisteban, C. O'Neill, M. Sywak, R. Clifton-Bligh, B. Bendlova, V. Sýkorová, Y. Wang, S. Liu, J. Zhao, S. Zhao, M. Xing
Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients
2018 P. Romeo, C. Colombo, R. Granata, G. Calareso, A.V. Gualeni, M. Dugo, L. De Cecco, M.G. Rizzetti, A. Zanframundo, A. Aiello, M.L. Carcangiu, A. Gloghini, S. Ferrero, L. Licitra, A. Greco, L. Fugazzola, L.D. Locati, M.G. Borrello
Letter regarding the article: "Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls" by Kern et al
2018 C. Colombo, L. Fugazzola, M. Muzza, M. Proverbio, V. Cirello
Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer
2018 X. Shen, G. Zhu, R. Liu, D. Viola, R. Elisei, E. Puxeddu, L. Fugazzola, C. Colombo, B. Jarzab, A. Czarniecka, A. Lam, C. Mian, F. Vianello, L. Yip, G. Riesco-Eizaguirre, P. Santisteban, C. O'Neill, M. Sywak, R. Clifton-Bligh, B. Bendlova, V. Sýkorová, M. Xing
Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients
2018 P. Romeo, C. Colombo, R. Granata, G. Calareso, A.V. Gualeni, M. Dugo, L. De Cecco, M.G. Rizzetti, A. Zanframundo, A. Aiello, M.L. Carcangiu, A. Gloghini, S. Ferrero, L. Licitra, A. Greco, L. Fugazzola, L.D. Locati, M.G. Borrello
Tumor and normal thyroid spheroids : from tissues to zebrafish
2018 V. Cirello, G. Gaudenzi, E. Grassi, C. Colombo, L. Vicentini, S. Ferrero, L. Persani, G. Vitale, L. Fugazzola
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment
2018 Y. Huang, S. Qu, G. Zhu, F. Wang, R. Liu, X. Shen, D. Viola, R. Elisei, E. Puxeddu, L. Fugazzola, C. Colombo, B. Jarzab, A. Czarniecka, A. Lam, C. Mian, F. Vianello, L. Yip, G. Riesco-Eizaguirre, P. Santisteban, C. O'Neill, M. Xing
MassARRAY-based simultaneous detection of hotspot somatic mutations and recurrent fusion genes in papillary thyroid carcinoma : the PTC-MA assay
2018 C. Pesenti, M. Muzza, C. Colombo, M.C. Proverbio, C. Faré, S. Ferrero, M. Miozzo, L. Fugazzola, S. Tabano
Genetic diagnosis of endocrine diseases by NGS: novel scenarios and unpredictable results and risks
2018 L. Persani, T. de Filippis, C. Colombo, D. Gentilini
BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer
2018 F. Wang, S. Zhao, X. Shen, G. Zhu, R. Liu, D. Viola, R. Elisei, E. Puxeddu, L. Fugazzola, C. Colombo, B. Jarzab, A. Czarniecka, A. Lam, C. Mian, F. Vianello, L. Yip, G. Riesco-Eizaguirre, P. Santisteban, C. O'Neill, M. Sywak, R. Clifton-Bligh, B. Bendlova, V. Sýkorová, Y. Wang, M. Xing
Primary Adrenal Insufficiency during Lenvatinib or Vandetanib and Improvement of Fatigue after Cortisone Acetate Therapy
2018 C. Colombo, S. De Leo, M. Di Stefano, G. Vannucchi, L. Persani, L. Fugazzola
Molecular markers for the classification of cytologically indeterminate thyroid nodules.
2019 M. Muzza, C. Colombo, G. Pogliaghi, O. Karapanou, L. Fugazzola
Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission Probability
2019 C. Colombo, M. Muzza, M.C. Proverbio, D. Tosi, D. Soranna, C. Pesenti, S. Rossi, V. Cirello, S. De Leo, N. Fusco, M. Miozzo, G. Bulfamante, L. Vicentini, S. Ferrero, A. Zambon, S. Tabano, L. Fugazzola
Absence of the MAP2K5 germline variants c.G961A and c.T1100C in a wide series of familial nonmedullary thyroid carcinoma Italian families
2019 V. Cirello, C. Colombo, L. Persani, L. Fugazzola
Genetic variants of PARP4 gene and PARP4P2 pseudogene in patients with multiple primary tumors including thyroid cancer.
2019 V. Cirello, C. Colombo, G. Pogliaghi, M. Proverbio, S. Rossi, E. Mussani, D. Tosi, G. Bulfamante, E. Bonoldi, G. Gherardi, L. Persani, L. Fugazzola
Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment
2020 L. Fugazzola, M. Di Stefano, S. Censi, A. Repaci, C. Colombo, F. Grimaldi, F. Magri, U. Pagotto, M. Iacobone, L. Persani, C. Mian
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
2020 K. Kim, S. Kim, J. Tan, X. Shen, D. Viola, R. Elisei, E. Puxeddu, L. Fugazzola, C. Colombo, B. Jarzab, A. Czarniecka, A. Lam, C. Mian, F. Vianello, L. Yip, G. Riesco-Eizaguirre, P. Santisteban, C. O'Neill, M. Sywak, R. Clifton-Bligh, B. Bendlova, V. Sýkorová, M. Xing
Body Composition and Leptin/Ghrelin Levels during Lenvatinib for Thyroid Cancer
2020 S. De Leo, C. Colombo, M. Di Stefano, A. Dubini, S. Cozzi, L. Persani, L. Fugazzola
Lenvatinib as first-line treatment for advanced thyroid cancer: long progression-free survival
2020 S. De Leo, M. Di Stefano, L. Persani, L. Fugazzola, C. Colombo
High Prevalence and Conservative Management of Acute Cholecystitis during Lenvatinib for Advanced Thyroid Cancer
2020 M. Di Stefano, C. Colombo, S. De Leo, M. Perrino, M. Viganò, L. Persani, L. Fugazzola
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile